Quality of life outcomes in proton and photon treated pediatric brain tumor survivors

Radiotherapy and Oncology

Volumn 113, Issue 1, 2014, Pages 89-94

  Yock, Torunn I ^a   Bhat, Sundeep ^b   Szymonifka, Jackie ^a   Yeap, Beow Y ^a   Delahaye, Jennifer ^a   Donaldson, Sarah S ^c   MacDonald, Shannon M ^a   Pulsifer, Margaret B ^a   Hill, Kristen S ^a   DeLaney, Thomas F ^a   Ebb, David ^a   Huang, Mary ^a   Tarbell, Nancy J ^a   Fisher, Paul Graham ^d   Kuhlthau, Karen A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KAISER PERMANENTE   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Late effects; Outcomes; Pediatric brain tumors; Proton radiotherapy; QoL

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASSESSMENT OF HUMANS; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEDSQL SCORE; PHOTON THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON THERAPY; QUALITY OF LIFE; BRAIN NEOPLASMS; PARENT; PHOTON; PRESCHOOL CHILD; PSYCHOLOGY; SURVIVOR; THERAPEUTIC USE; TREATMENT OUTCOME;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PARENTS; PHOTONS; PROSPECTIVE STUDIES; PROTON THERAPY; QUALITY OF LIFE; SURVIVORS; TREATMENT OUTCOME;

EID: 84922753196     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.08.017     Document Type: Article

References (33)

1. Armstrong GT, Stovall M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res 2010; 174: 840-50.
2. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-82.
3. Meeske KA, Patel SK, Palmer SN, Nelson MB, Parow AM. Factors associated with health-related quality of life in pediatric cancer survivors. Pediatr Blood Cancer 2007; 49: 298-305.
4. Diller L, Chow EJ, Gurney JG, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 2009; 27: 2339-55.
5. Laughton SJ, Merchant TE, Sklar CA, et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 2008; 26: 1112-8.
6. Mulhern RK, White HA, Glass JO, et al. Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc 2004; 10: 180-9.
7. Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke U. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 2008; 51: 110-7.
8. Packer RJ. Childhood brain tumors: accomplishments and ongoing challenges. J Child Neurol 2008; 23: 1122-7.
9. Meeske K, Katz ER, Palmer SN, Burwinkle T, Varni JW. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer 2004; 101: 2116-25.
10. Brice L, Weiss R, Wei Y, et al. Health-related quality of life (HRQoL): the impact of medical and demographic variables upon pediatric recipients of hematopoietic stem cell transplantation. Pediatr Blood Cancer 2011; 57: 1179-85.
11. Johnson DL, McCabe MA, Nicholson HS, et al. Quality of long-term survival in young children with medulloblastoma. J Neurosurg 1994; 80: 1004-10.
12. Reimers TS, Mortensen EL, Nysom K, Schmiegelow K. Health-related quality of life in long-term survivors of childhood brain tumors. Pediatr Blood Cancer 2009; 53: 1086.
13. Ladra ML, Edgington SK, Mahajan A, et al. A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiother Oncol 2014; 113: 97-103.
14. Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 2005; 63: 362-72.
15. Yock T, Schneider R, Friedmann A, Adams J, Fullerton B, Tarbell N. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys 2005; 63: 1161-8.
16. Palm A, Johansson KA. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors. Acta Oncol 2007; 46: 462-73.
17. Hoffman KE, Yock TI. Radiation therapy for pediatric central nervous system tumors. J Child Neurol 2009; 24: 1387-96.
18. Childs SK, Kozak KR, Friedmann AM, et al. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects. Int J Radiat Oncol Biol Phys 2012; 82: 635-42.
19. Yock TI, Yeap BY, Pulsifer MB, et al. Results from a prospective trial of proton radiotherapy for medulloblastoma: clinical outcomes including hearing and neurocognitive. Int J Radiat Oncol Biol Phys 2011; 81: S113.
20. Kuhlthau KA, Pulsifer MB, Yeap BY, et al. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol 2012; 30: 2079-86.
21. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 2003; 3: 329-41.
22. Varni JW, Burwinkle TM, Katz ER. The PedsQL in pediatric cancer pain: a prospective longitudinal analysis of pain and emotional distress. J Dev Behav Pediatr 2004; 25: 239-46.
23. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module. Cancer 2002; 94: 2090-106.
24. Varni JW, Limbers CA, Burwinkle TM. Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 generic core scales. Health Qual Life Outcomes 2007; 5: 43.
25. Bhat SR, Goodwin TL, Burwinkle TM, et al. Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol 2005; 23: 5493-500.
26. Penn A, Lowis SP, Stevens MC, et al. Family, demographic and illness-related determinants of HRQL in children with brain tumours in the first year after diagnosis. Pediatr Blood Cancer 2009; 53: 1092-9.
27. Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 generic core scales in healthy and patient populations. Med Care 2001; 39: 800-12.
28. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004; 5: 399-408.
29. Moeller BJ, Chintagumpala M, Philip JJ, et al. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy. Radiat Oncol 2011; 6: 58.
30. McDougall J, Tsonis M. Quality of life in survivors of childhood cancer: a systematic review of the literature (2001-2008). Supp Care Cancer 2009; 17: 1231-46.
31. Merchant TE, Kiehna EN, Li C, et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys 2006; 65: 210-21.
32. Paganetti H, Athar BS, Moteabbed M, Adams JA, Schneider U, Yock TI. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field. Phys Med Biol 2012; 57: 6047-61.
33. Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil 2004; 7: 1-14 [discussion 15-6].